In light of the growing prevalence of CKD worldwide with an increasing trend in total medicare expenditures, the organ-protective effects of NAC should be tested in uremic patients with urgent need of new therapeutics.
← all excerpts
Translational Medicine in Pulmonary-Renal Crosstalk: Therapeutic Targeting of p-Cresyl Sulfate Triggered Nonspecific ROS and Chemoattractants in Dyspneic Patients with Uremic Lung Injury.
1
—
—